RSVP for the January 2025 EL-PFDD Meeting
FAST and ASF will co-host a virtual Externally Led-PFDD Meeting on January 29, 2025, giving the Angelman syndrome community a direct voice with the FDA on therapy development.
FAST and ASF Announce their Partnership with the Institute for Gene Therapies
ASF and FAST partner with the Institute for Gene Therapies to push for policy changes that ensure patients can access cutting-edge gene therapies for Angelman syndrome.